A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Ian W. Flinn, Nancy L. Bartlett, Kristie A. Blum, Kirit M. Ardeshna, Ann S. Lacasce, Christopher R. Flowers, Andrei R. Shustov, Kenneth S. Thress, Patrick Mitchell, Fred Zheng, Jeffrey M. Skolnik, Jonathan W. Friedberg
Dive into the research topics of 'A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)'. Together they form a unique fingerprint.